2,4-Oxazolidinedione, 5-[1,2-dihydro-6-(2-naphthalenyl)-2-oxo-3-pyridinyl]-5-(1-methylethyl)- manufacturers
- EP3 antagonist 3
-
- $1240.00
-
2026-04-21
- CAS:1227827-88-4
- Purity:
- Supply Ability: 10g
|
| | 2,4-Oxazolidinedione, 5-[1,2-dihydro-6-(2-naphthalenyl)-2-oxo-3-pyridinyl]-5-(1-methylethyl)- Basic information |
| | 2,4-Oxazolidinedione, 5-[1,2-dihydro-6-(2-naphthalenyl)-2-oxo-3-pyridinyl]-5-(1-methylethyl)- Chemical Properties |
| density | 1.328±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 250 mg/mL (689.88 mM; Need ultrasonic) | | form | Solid | | pka | 5.09±0.70(Predicted) | | color | Off-white to light yellow |
| | 2,4-Oxazolidinedione, 5-[1,2-dihydro-6-(2-naphthalenyl)-2-oxo-3-pyridinyl]-5-(1-methylethyl)- Usage And Synthesis |
| Uses | EP3 antagonist 3 (compound 2) is an orally active, potent and selective EP3 antagonist, with a pKi of 8.3. EP3 antagonist 3 shows excellent pharmacokinetic properties. EP3 antagonist 3 can be used for overactive bladder (OAB) research[1]. | | IC 50 | EP3: 8.3 (pKi) | | References | [1] Jin J, et al. Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists. ACS Med Chem Lett. 2010 May 14;1(7):316-20. DOI:10.1021/ml100077x |
| | 2,4-Oxazolidinedione, 5-[1,2-dihydro-6-(2-naphthalenyl)-2-oxo-3-pyridinyl]-5-(1-methylethyl)- Preparation Products And Raw materials |
|